Nexentis Technologies (NXTS) Market Capitalization (2018 - 2026)
Nexentis Technologies (NXTS) posted Market Capitalization of $3.5 million for Q2 2026, up 84.85% on a QoQ basis from $1.9 million in Q4 2025, and down 97.87% year-over-year from $165.5 million in Q2 2025.
Analysis
Nexentis Technologies (NXTS) Market Capitalization (2018 - 2026) Analysis & Trends
Nexentis Technologies has reported Market Capitalization for 9 years, with the latest figure at $3.5 million in Q2 2026.
- On a quarterly basis, Market Capitalization fell 97.87% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 97.87% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 96.25% from the prior year.
- Market Capitalization was $3.5 million for Q2 2026 at Nexentis Technologies, up from $1.9 million in the prior quarter.
- The five-year high for Market Capitalization was $4.0 billion in Q1 2022, with the low at $1.9 million in Q4 2025.
- Average Market Capitalization over 5 years is $678.9 million, with a median of $149.0 million recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Market Capitalization jumped 190.74% in 2025, then sank 97.87% in 2026.
- Over 5 years, Market Capitalization stood at $647.1 million in 2022, then plunged by 87.01% to $84.0 million in 2023, then sank by 39.62% to $50.7 million in 2024, then plunged by 96.25% to $1.9 million in 2025, then surged by 84.85% to $3.5 million in 2026.
- The last three Market Capitalization figures came in at $3.5 million (Q2 2026), $1.9 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Nexentis Technologies | 1.40 Mn | -7.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.52 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 165.46 Mn |
| Mar 31, 2025 | 149.01 Mn |
| Dec 31, 2024 | 50.75 Mn |
| Sep 30, 2024 | 50.93 Mn |
| Jun 30, 2024 | 56.91 Mn |
| Mar 31, 2024 | 134.94 Mn |
| Dec 31, 2023 | 84.04 Mn |
| Sep 30, 2023 | 180.98 Mn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 776.14 Mn |
| Dec 31, 2022 | 647.09 Mn |
| Sep 30, 2022 | 1.72 Bn |
| Jun 30, 2022 | 2.38 Bn |
| Mar 31, 2022 | 4.00 Bn |
| Dec 31, 2021 | 2.76 Bn |
| Sep 30, 2021 | 4.39 Bn |
| Jun 30, 2021 | 4.19 Bn |